Abstract
This paper uses a model developed from the international political economy (IPE) school, to address the structure of the biotechnology industry. In particular, by focusing upon four primary structural elements of the industry, knowledge, production, finance and security with key secondary considerations of biosafety, public opinion and choice of intellectual property regime, the development of biotechnology companies from developed countries fits within a triad dominated industry with specific interests towards firms from developing countries. The activities of a sample of US National Association of Securities Dealers Stock Market (NASDAQ) quoted biotechnology firms are investigated to support the model which concludes by the observation of the need to include both strategic and traditionally non strategic interests when reviewing policy formulation and objectives for firms in the biotechnology industry.
Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".
The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.